Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model

Journal of Pineal Research

Volumn 42, Issue 3, 2007, Pages 247-253

  Saravanan, Karuppagounder S ^a   Sindhu, Kizhakke M ^a   Mohanakumar, Kochupurackal P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Free radical scavenger; Glutathione; Melatonin; Mitochondrial complex I; Parkinson's disease; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE; HYDROXYL RADICAL; MELATONIN; NEUROPROTECTIVE AGENT; ROTENONE; SCAVENGER; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CYTOSOLIC FRACTION; DRUG EFFECT; ELECTROCHEMICAL ANALYSIS; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW DRUG DOSE; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; RAT; SPECTROPHOTOMETRY; SUBSTANTIA NIGRA; TREATMENT OUTCOME;

ANIMALS; CATALASE; GLUTATHIONE; HYDROXYL RADICAL; MALE; MELATONIN; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE; SUBMITOCHONDRIAL PARTICLES; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE;

EID: 33847675291     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2006.00412.x     Document Type: Article

References (68)

1. REITER RJ, RICHARDSON BA, JOHNSON LY et al. Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science 1980; 210:1372-1373.
2. SACK RL, LEWY AJ, ERB DL et al. Human melatonin production decreases with age. J Pineal Res 1986; 3:379-388.
3. REITER RJ. The melatonin rhythm: both a clock and a calendar. Experientia 1993; 49:654-664.
4. REPPERT SM, WEAVER DR, EBISAWA T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13:1177-1185.
5. DUBOCOVICH ML, MANSANA MI, BENLOUCIF S. Molecular pharmacology and function of melatonin receptor subtypes. Adv Exp Med Biol 1999; 460:181-190.
6. REITER RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56:359-384.
7. REITER RJ, TAN DX, MANCHESTER LC et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34:237-256.
8. TAN DX, REITER RJ, MANCHESTER LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad-spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002; 2:181-198.
9. CAGNOLI CM, ATABAY C, KHARLAMOVA E et al. Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 1995; 18:222-226.
10. TAN DX, CHEN LD, POEGGELER B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
11. PIERI C, MARRA M, MORONI F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 55:271-276.
12. THOMAS B, MOHANAKUMAR KP. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. J Pineal Res 2004; 36:25-32.
13. TAN DX, REITER RJ, CHEN LD et al. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 1994; 15:215-218.
14. GUISTI P, GUSELLA M, LIPARTITI M et al. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl-D-aspartate excitotoxicity. Exp Neurol 1995; 131:39-46.
15. UZ T, GUISTI P, FRANCESHINI D et al. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience 1996; 73:631-636.
16. CARNEIRO RC, REITER RJ. Melatonin protects against lipid peroxidation induced by delta-aminolevulinic acid in rat cerebellum, cortex and hippocampus. Neuroscience 1998; 82:293-298.
17. SOUTHGATE G, DAYA S. Melatonin reduces quinolinic acid-induced lipid peroxidation in rat brain homogenate. Metab Brain Dis 1999; 14:165-171.
18. GUENTHER AL, SCHMIDT SI, LAATSCH H et al. Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 2005; 39:251-260.
19. ONUKI J, ALMEIDA EA, MEDEIROS MH et al. Inhibition of 5-aminolevulinic acid-induced DNA damage by melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, quercetin or resveratrol. J Pineal Res 2005; 38:107-115.
20. UNGERSTEDT U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 1971; 367:95-122.
21. BURNS RS, MARKEY SP, PHILLIPS JM et al. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man. Can J Neurol Sci 1984; 11:166-168.
22. MOHANAKUMAR KP, DE BARTOLOMEIS A, WU RM et al. Ferrous-citrate complex and nigral degeneration: Evidence for free radical formation and lipid peroxidation. Ann NY Acad Sci 1994; 738:392-399.
23. BETARBET R, SHERER TB, MACKENZIE G et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000; 12:1301-vv1306.
24. SARAVANAN KS, SINDHU KM, MOHANAKUMAR KP. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease. Brain Res 2005; 1049:147-155.
25. CHANDRA G, GANGOPADHYAY PK, Senthil Kumar KS et al. Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats. Brain Res 2006; 1075:81-92.
26. CHIUEH CC, MIYAKE H, PENG MT. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv Neurol 1993; 60:251-258.
27. MOHANAKUMAR KP, THOMAS B, SHARMA SM et al. Nitric oxide: an antioxidant and neuroprotector. Ann N Y Acad Sci 2002; 962:389-401.
28. TATTON WG, CHALMERS-REDMAN R, BROWN D et al. Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann Neurol 2003; 53:S61-S70.
29. MIZUNO Y, OHTA S, TANAKA M et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989; 163:1450-1455.
30. MOHANAKUMAR KP, MURALIKRISHNAN D. Neurochemical mechanisms underlying neuroprotective actions of bromocriptine, salicylate, D- and L-deprenyl in neurodegeneration caused by MPTP. In: Neurotoxic Factors in Parkinson's Disease and Related Disorders. Collins MA, Storch A, eds. Kluwer Academic/Plenum, New York, 2000; pp. 289-293.
31. MOLLER JC, OERTEL WH. Pramipexole in the treatment of Parkinson's disease: new developments. Exp Rev Neurother 2005; 5:581-586.
32. SARAVANAN KS, SINDHU KM, SENTHILKUMAR KS et al. L-Deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats. Neurochem Int 2006; 49:28-40.
33. DABBENI-SALA F, DI SANTO S, FRANCESCHINI D et al. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 2001; 15:164-170.
34. ANTOLIN I, MAYO JC, SAINZ RM et al. Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Res 2002; 943:163-173.
35. ACUNA-CASTROVIEJO D, COTO-MONTES A, GAIA MONTI M et al. Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci 1997; 60:23-29.
36. ITZHAK Y, MARTIN JL, BLACK M. Effect of melatonin on methamphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization. Neuropharmacology 1998; 37:781-791.
37. MORGAN WW, NELSON JF. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway. Brain Res 2001; 921:115-121.
38. KHALDY H, ESCAMES G, LEON J et al. Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion. Neurobiol Aging 2003; 24:491-500.
39. SINDHU KM, SARAVANAN KS, MOHANAKUMAR KP. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion. Brain Res 2005; 1051:25-34.
40. COULOM H, BIRMAN S. Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J Neurosci 2004; 24:10993-10998.
41. 2+-induced mitochondrial oxidative stress and PC12 cell death. Antioxid Redox Signal 2005; 9:1110-1116.
42. PAXINOS G, WATSON C. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, 1998; pp. 1-120.
43. COHN VH, LYLE A. Fluorimetric assay for glutathione. Anal Biochem 1966; 14:434-440.
44. MARKLUND S, MARKLUND G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47:469-474.
45. AEBI H. Catalase in vitro. Methods Enzymol 1984; 105:121-126.
46. REITER RJ, TAN DX, POEGGELER B et al. Melatonin is a free radical scavenger implications for ageing and age related diseases. Ann N Y Acad Sci 1994; 719:1-12.
47. REITER RJ, MELCHIORRI D, SEWERYNEK E et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18:1-11.
48. SKAPER SD, FLOREANI M, CECCON M et al. Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann N Y Acad Sci 1999; 890:107-118.
49. KHALDY H, ESCAMES G, LEÓN J. Comparative effects of melatonin, L-deprenyl, Trolox and ascorbate in the suppression of hydroxyl formation during dopamine auto-oxidation in vitro. J Pineal Res 2000; 24:215-218.
50. JENNER P. Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci 2001; 24:245-247.
51. JENNER P. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurol Scand Suppl 1993; 146:6-13.
52. + in vivo. Eur J Pharmacol 1993; 243:241-247.
53. MURALIKRISHNAN D, MOHANAKUMAR KP. Neuroprotection by bromocryptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice. Faseb J 1998; 12:905-912.
54. MOHANAKUMAR KP, MURALIKRISHNAN D, THOMAS B. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity. Brain Res 2000; 864:281-290.
55. MURALIKRISHNAN D, SAMANTARAY S, MOHANAKUMAR KP. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity. Synapse 2003; 50:7-13.
56. MELCHIORRI D, REITER RJ, SEWERYNEK E et al. Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions. Faseb J 1995; 9:1205-1210.
57. 2-induced lipid peroxidation in homogenates of different rat brain regions. J Pineal Res 1995; 1:51-56.
58. SIAN J, DEXTER DT, LEES AJ et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994; 36:348-355.
59. + toxicity in nigral dopaminergic neurons. Neuroreport 1996; 7:921-923.
60. FLOREANI M, SKAPER SD, FACCI L et al. Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. Faseb J 1997; 11:1309-1315.
61. URATA Y, HONMA S, GOTO S et al. Melatonin induces gammaglutymlcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic Biol Med 1999; 27:838-847.
62. WINIARSKA K, FRACZYK T, MALINSKA D et al. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res 2006; 40:160-176.
63. REITER RJ, TAN DX, OSUNA C et al. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Sci 2000; 7:444-458.
64. LIU F, NG TB. Effect of pineal indoles on activities of the antioxidant defense enzymes superoxide dismutase, catalase, and glutathione reductase, and levels of reduced and oxidized glutathione in rat tissues. Biochem Cell Biol 2000; 78:447-453.
65. KOTLER M, RODRIGUEZ C, SAINZ RM et al. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998; 24:83-89.
66. MAYO JC, SAINZ RM, ANTOLI I et al. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002; 59:1706-1713.
67. MONTILLA P, TUNEZ I, MUNOZ MC et al. Antioxidative effect of melatonin in rat brain oxidative stress induced by adriamycin. Rev Esp Fisiol 1997; 53:301-305.
68. MAYO JC, SAINZ RM, URIA H et al. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. J Pineal Res 1998; 24:179-192.